All Rolanda Londt articles
-
NewsEbola vaccine induces T cell cross-reactivity against Bundibugyo virus in humans
A vaccine developed against Ebola virus may offer some immune protection against the related Bundibugyo ebolavirus, for which no licensed vaccine currently exists. Researchers found that a single dose triggered T cells capable of recognising BDBV, raising the possibility that existing vaccines could provide a degree of cross-protection during outbreaks.